Diabetes Prevention Program Outcomes Study
clinical trial
Press Enter · cited answer in seconds
0 sources
Diabetes Prevention Program Outcomes Study
Summary
Diabetes Prevention Program Outcomes Study is a clinical trial[1].
Key Facts
- Diabetes Prevention Program Outcomes Study is in the country of United States[2].
- Diabetes Prevention Program Outcomes Study's instance of is recorded as clinical trial[3].
- Diabetes Prevention Program Outcomes Study's start time is recorded as +2002-09-30T00:00:00Z[4].
- Diabetes Prevention Program Outcomes Study's end time is recorded as +2024-10-31T00:00:00Z[5].
- Diabetes Prevention Program Outcomes Study's sponsor is recorded as National Institute of Diabetes and Digestive and Kidney Diseases[6].
- Diabetes Prevention Program Outcomes Study's main subject is recorded as obesity[7].
- Diabetes Prevention Program Outcomes Study's main subject is recorded as diabetes[8].
- Diabetes Prevention Program Outcomes Study's number of participants is recorded as {'unit': '1', 'amount': '+2779'}[9].
- Diabetes Prevention Program Outcomes Study's title is recorded as Diabetes Prevention Program Outcomes Study[10].
- Diabetes Prevention Program Outcomes Study's short name is recorded as DPPOS[11].
- Diabetes Prevention Program Outcomes Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+25'}[12].
- Diabetes Prevention Program Outcomes Study's ClinicalTrials.gov ID is recorded as NCT00038727[13].
- Diabetes Prevention Program Outcomes Study's research intervention is recorded as metformin[14].
- Diabetes Prevention Program Outcomes Study's clinical trial phase is recorded as phase III clinical trial[15].
- Diabetes Prevention Program Outcomes Study's research site is recorded as George Washington University[16].
- Diabetes Prevention Program Outcomes Study's study type is recorded as interventional study[17].